Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

N Ostrerova-Golts1, L Petrucelli, J Hardy

  • 1Departments of Pharmacology, Loyola University Medical Center, Maywood, Illinois 60153, USA.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|August 10, 2000
PubMed
Summary

Iron and free radicals, like dopamine, promote alpha-synuclein aggregation and toxicity in Parkinson's disease (PD) models. This suggests a role for these factors in Lewy body formation and neuronal death in PD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid-lowering treatment is related to decreased risk of dementia: a population-based study (FINRISK).

Neuro-degenerative diseases·2010
Same author

LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins.

Neuro-degenerative diseases·2010
Same author

Serum total cholesterol, statins and cognition in non-demented elderly.

Neurobiology of aging·2007
Same author

Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.

Acta neurologica Scandinavica. Supplementum·2006
Same author

Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease.

Neurology·2006
Same author

Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.

Experimental neurology·2005

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Parkinson's disease (PD) is a common neurodegenerative disorder characterized by Lewy bodies and dopaminergic neuron loss.
  • Alpha-synuclein aggregation in Lewy bodies suggests its involvement in PD pathogenesis.
  • Mutations in alpha-synuclein are linked to familial forms of PD.

Purpose of the Study:

  • To investigate the role of iron and free radical generators in alpha-synuclein aggregation and toxicity.
  • To determine how different alpha-synuclein variants (wild-type, A53T, A30P) influence aggregation and cellular vulnerability.

Main Methods:

  • Utilized human BE-M17 neuroblastoma cells overexpressing different forms of alpha-synuclein.
  • Exposed cells to iron and free radical generators (dopamine, hydrogen peroxide).

Related Experiment Videos

  • Assessed intracellular aggregate formation using immunocytochemistry, electron microscopy, and thioflavine S staining; measured cell toxicity.

    • Main Results:

    • Iron and free radicals significantly stimulated the production of intracellular alpha-synuclein and ubiquitin aggregates.
    • Aggregate formation correlated with the expression level and type of alpha-synuclein (A53T > A30P > wild-type).
    • Overexpression of alpha-synuclein increased cellular vulnerability to iron-induced toxicity, mirroring the aggregation rank order.

    Conclusions:

    • Alpha-synuclein may act synergistically with iron and dopamine to drive Lewy body pathology in Parkinson's disease.
    • This interaction could contribute to the cell death observed in PD.
    • Findings highlight potential therapeutic targets related to iron and oxidative stress in PD.